- VernacularTitle:肺癌侵及心脏及大血管的外科手术治疗
- Author:
Jian-Guang YI
1
;
Mao-Ting YE
;
Wei CHENG
;
Xin LIU
;
Yong-Bo CHENG
;
Xian-Pu ZHANG
Author Information
- Keywords: lung cancer; invasion of the heart and large blood vessels; surgical treatment; 5-year survival rate
- From: Journal of Regional Anatomy and Operative Surgery 2018;27(3):217-220
- CountryChina
- Language:Chinese
- Abstract: Objective To investigate the surgical treatment of lung cancer invading the heart and large blood vessels.Methods The clinical data of 96 cases of lung cancer invading the heart and large blood vessel admitted into our hospital from March 2009 to March 2012 were retrospectively analyzed,especially the surgical methods,postoperative complications and 5-year survival rate.Results The 5-year survival rate of lung cancer patients who infringed the atrium and superior vena cava had no significant difference (P > 0.05).However,the 5-year survival rate and median survival time of lung cancer patients who infringed the atrium and superior vena cava were significantly lower than those of lung cancer patients who infiltrated the pulmonary artery,and the difference was statistically significant(P < 0.05).The median survival time of patients with lung cancer invading the atrium was lower than that of patients with lung cancer invading the superior vena cava,and the difference was statistically significant(P < 0.05).The range of tumor involvement after operation was significantly lower than that before operation,and the difference was statistically significant(P < 0.05).Three types of surgical methods were used for patients according to different invading sites,and the complication incidence of 3 surgical methods were similar with no statistically significant difference(P > 0.05).Conclusion Surgical treatment for lung cancer invading the heart and large blood vessels has a good efficacy,which can improve the involved tumor range of patients without serious postoperative complications and provide opportunity for patients with comprehensive postoperative treatment.In addition,it can significantly improve the 5-year survival rate of patients.